4.5 Article

Inferring changepoint times of medial temporal lobe morphometric change in preclinical Alzheimer's disease

期刊

NEUROIMAGE-CLINICAL
卷 5, 期 -, 页码 178-187

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.nicl.2014.04.009

关键词

-

资金

  1. National Institutes of Health [U01-AG03365, P50- AG005146, P41-EB015909, R01-EB000975]
  2. NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015909, R01EB000975] Funding Source: NIH RePORTER
  3. NATIONAL INSTITUTE ON AGING [U01AG033655, U19AG033655, P50AG005146] Funding Source: NIH RePORTER

向作者/读者索取更多资源

This paper uses diffeomorphometry methods to quantify the order in which statistically significant morphometric change occurs in three medial temporal lobe regions, the amygdala, entorhinal cortex (ERC), and hippocampus among subjects with symptomatic and preclinical Alzheimer's disease (AD). Magnetic resonance imaging scans were examined in subjects who were cognitively normal at baseline, some of whom subsequently developed clinical symptoms of AD. The images were mapped to a common template, using shape-based diffeomorphometry. The multidimensional shape markers indexed through the temporal lobe structures were modeled using a changepoint model with explicit parameters, specifying the number of years preceding clinical symptom onset. Our model assumes that the atrophy rate of a considered brain structure increases years before detectable symptoms. The results demonstrate that the atrophy changepoint in the ERC occurs first, indicating significant change 8-10 years prior to onset, followed by the hippocampus, 2-4 years prior to onset, followed by the amygdala, 3 years prior to onset. The ERC is significant bilaterally, in both our local and global measures, with estimates of ERC surface area loss of 2.4% (left side) and 1.6% (right side) annually. The same changepoint model for ERC volume gives 3.0% and 2.7% on the left and right sides, respectively. Understanding the order in which changes in the brain occur during preclinical AD may assist in the design of intervention trials aimed at slowing the evolution of the disease. (C) 2014 The Authors. Published by Elsevier Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据